Liminatus Pharma, Inc. Class A Common Stock (LIMN) Stock
LIMN Key Statistics
About Liminatus Pharma, Inc. Class A Common Stock
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.
CEO: Chris Kim. Company website
LIMN — Frequently Asked Questions
What is the LIMN stock price today?
Liminatus Pharma, Inc. Class A Common Stock (LIMN) trades at $0.14, down 6.60% on the day, as of Sep 20, 2026 15:01 UTC.
What is Liminatus Pharma, Inc. Class A Common Stock's market cap?
Liminatus Pharma, Inc. Class A Common Stock has a market capitalisation of $3.76M, calculated from the live LIMN share price and shares outstanding.
What is the P/E ratio of LIMN?
LIMN has no meaningful price-to-earnings ratio: Liminatus Pharma, Inc. Class A Common Stock lost $2.91 per share over the last twelve months, and a P/E is only defined on positive earnings.
How much revenue does Liminatus Pharma, Inc. Class A Common Stock make?
Liminatus Pharma, Inc. Class A Common Stock generated revenue of $0.00 over the trailing twelve months.
What is the 52-week range for LIMN?
LIMN has traded between $0.10 and $0.36 over the past 52 weeks, and the last price is 60.9% below that high.
Is Liminatus Pharma, Inc. Class A Common Stock profitable?
Yes. Liminatus Pharma, Inc. Class A Common Stock keeps 0.00% of revenue as net income over the trailing twelve months.
What sector is Liminatus Pharma, Inc. Class A Common Stock in?
Liminatus Pharma, Inc. Class A Common Stock is classified under the Healthcare sector and the Biotechnology industry, and is domiciled in US .
Who is the CEO of Liminatus Pharma, Inc. Class A Common Stock?
Chris Kim is the chief executive of Liminatus Pharma, Inc. Class A Common Stock, which employs 3 people.
Where can I track LIMN in real time?
QFI Terminal shows LIMN with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See LIMN live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open LIMN in Terminal See plans